This trial is evaluating whether reSET-O app will improve 3 primary outcomes and 2 secondary outcomes in patients with Opioid Abuse. Measurement will happen over the course of 30 days.
This trial requires 60 total participants across 2 different treatment groups
This trial involves 2 different treatments. ReSET-O App is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
In addition to the standard prescription opioid treatments such as methadone, buprenorphine, naloxone, naltrexone, and alprazolam, some of the illicit alternatives include heroin, cocaine, and cannabis.\n
Nausea and vomiting are the most common initial symptom of opioid addiction, and are associated with other signs and symptoms that also point towards addiction, such as inability to control use, difficulty paying for prescription medications, and diminished enjoyment of life.
Although not yet a cure, a combination of medication and rehabilitation can help people with opioid misuse to live healthier lives, by reducing the risk for death, chronic illness, and illicit drug use.
In many cases, patients are unaware of the dangers, implications, and consequences of opioid abuse, and are even unaware that they are abusing morphine. Many of the abusers are not aware of their addiction or its consequences. It is hoped that appropriate educational campaigns and awareness campaigns will increase the rate of recognition of opioid dependence and of its proper management through detoxification and support. The use of opioids on the prescription drug register may improve their availability as controlled medications. Increasing the availability of Naloxone, an abortifier for heroin overdoses, which has been shown to be both effective and inexpensive, is also recommended.
About 12.5 million Americans have ever taken opioids at some point in their life, and 5.1 million Americans reported taking opioids on a daily basis during one or more of the last 12 months. Thus, a substantial minority of the population may have experienced opioid abuse. Most commonly, individuals who misuse opioids report misusing heroin or pills. Opioid use appears to be associated with a wide range of health, social, and psychological problems.
Factors which contribute to substance abuse include a history of childhood trauma, abuse or neglect, the belief that a substance use disorder is incurable, tolerance, reinforcement, and emotional distress.
These data are consistent with research that suggests that individuals who seek medically-related care and abuse prescription painkillers typically are trying to reduce withdrawal symptoms associated with opioid use.
Participants who used or contemplated the use of ROT have a high prevalence of opioid and substance use disorders. Providers should consider screening those who are prescribed ROT for opioid or substance use disorders and provide support for those who need it.
The findings from this study reflect an issue of delay to the detection of opioid abuse. The rate of opioid use increased from 1990 to 2000. The number of adolescents who began using opioids was nearly the triple of adolescents who developed other drug-related problems. Intervention on the early age with early detection may be very useful to prevent addiction.
It is extremely likely that patients presenting with acute lower back pain will be taking opioids at some point before the presentation at which point this must be considered by doctors to ensure the safety of their patients when analgesics are used. An awareness of the risk of opioids is therefore important to help preserve patients' lives. Given that more than 200,000 (9.9%) of those admitted to hospital are admitted with serious opioid misuse and another 1.8-3.1 million (9.1%) with misuse in the community, it is apparent that opioid misuse can be a substantial public health problem in the UK.
Adding reset-o treatment with any other treatment does not appear to produce any better results than adding the reset-o monotherapy with the same combination of drugs.
Opioid-addicted families may constitute a particular subgroup, and more attention is warranted in identifying and treating addiction to prevent the potential of a familial basis.